8-K1.022.013.01
SECURITIES AND EXCHANGE COMMISSION
CRNX to acquire platform ($10B)
EDGARCRNX: SECURITIES AND EXCHANGE COMMISSION
Crinetics Pharmaceuticals Inc (CRNX) just filed. CRNX to acquire platform ($10B) (8-K 2026-09-01). Exhibit numbers: Deal $10B. Why it matters: Transaction value about $10B
Those exhibit numbers sit next to the income-statement cache: Latest reported CRNX revenue for 2025-09-30 was $143.0K. Net income was -$130.1M. Revenue was down 86.1% from 2025-06-30 to 2025-09-30. CRNX currently screens at market cap $2.76B. The CRNX filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Crinetics Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
8-KEX-99.11.022.013.013.03
SECURITIES AND EXCHANGE COMMISSION
CRNX to acquire platform ($10B)
- Deal
- $10B
Why it matters
- Transaction value about $10B
0
10-K
0
10-Q
8
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all CRNX filings.
Frequently asked questions
What did CRNX just say?
CRNX to acquire platform ($10B)
Where are CRNX SEC filings?
8 cached filings are on this page. EDGAR remains the official archive (CIK 0001658247).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.